1800 202 8726
Cetuximab myths corrected

Cetuximab Myths: — What the Evidence Actually Shows

Some of what you have heard about cetuximab is half-true, and some of it is wrong in ways that matter. This page corrects the most common claims and explains why they spread.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed August 2026

  • Rash does not equal response — A skin reaction is expected on cetuximab, but it is not a reliable measure of whether the drug is working for you.
  • Cetuximab is not chemotherapy — It is a monoclonal antibody that targets a specific receptor on cancer cells, not a broad-spectrum cell-killing agent.
  • It only works for some colorectal cancers — RAS testing must show no mutation before cetuximab is recommended for bowel cancer. The drug does not help if the mutation is present.
  • Never adjust your dose at home — The rash is manageable. Stopping or skipping cetuximab on your own because of skin symptoms is not the right response.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The most repeated myth about cetuximab is that a worse rash means the drug is working better. Evidence cited by ESMO shows a loose population-level association, but this does not hold for individual patients. Scans and tumour markers are how your oncologist decides whether cetuximab is working — not your skin.

What do people get wrong about cetuximab?

The worse the rash, the better the drug is working.

Some studies found a loose association between rash severity and outcomes at a population level, which is where this claim comes from. ESMO guidance is clear that it does not translate to individual patients. A severe rash means your skin needs care. Your oncologist uses imaging and tumour markers to assess response, not how your face looks.

Cetuximab is a type of chemotherapy.

Cetuximab is a monoclonal antibody — a protein engineered to attach to the EGFR receptor on the surface of cancer cells. Chemotherapy works by targeting rapidly dividing cells broadly. Cetuximab works by blocking one specific growth signal. The rash appears because EGFR is also present in skin cells. That is an on-target effect, not a toxicity in the chemotherapy sense.

Cetuximab works for any bowel cancer.

In colorectal cancer, cetuximab is only effective when the RAS genes in the tumour are not mutated. KRAS and NRAS testing is required before starting, because giving cetuximab to someone with a RAS mutation does not help and still exposes them to side effects. This is why your team tested your tumour DNA before recommending it.

The rash means you are allergic to cetuximab and should stop.

The acneiform rash — a pimple-like eruption on the face, chest and back — is an expected, on-target effect of EGFR inhibition in skin cells. It is not an allergic reaction. It is manageable, and your team can advise on skincare and prescribe a low-dose antibiotic if needed. Stopping cetuximab at home because of a rash is not the right response.

No rash means the drug is not working.

Some patients have a mild or absent skin reaction and still respond to treatment. The only way to know whether cetuximab is working is through scans and clinical assessment. Do not adjust your expectations of treatment based on your skin. Ask your oncologist when your first response assessment is scheduled if you are unsure.

What should you actually do when the rash appears?

The rash typically starts within the first two weeks, usually on the face, and can spread to the chest and back. It looks like acne but behaves differently — it is caused by EGFR inhibition in skin cells, not by blocked pores, so acne products you have used before may not help and can irritate.

Tell your team as soon as you notice it. Many oncologists start a moisturising routine before the first infusion, because managing the skin early keeps the rash from becoming severe.

A rash that is painful, weeping, or covering a large area of your body needs same-day review. If the rash is significantly affecting your daily life, a dose adjustment may be considered — but that is a decision your oncologist makes, not one you make by stopping the drug at home.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

How should you care for your skin during cetuximab?

  • Use a fragrance-free moisturiser on your face, chest and back from the day of your first infusion — before the rash appears.
  • Apply SPF 30 or higher sunscreen to exposed skin before going outdoors — sun exposure worsens the rash.
  • Do not use alcohol-based toners, salicylic acid or harsh acne products on affected skin without asking your team first.
  • Tell your team before applying any traditional or herbal remedy to the rash — some ingredients can interact with or worsen the skin reaction.
  • Report any rash that is painful, crusting, weeping or spreading rapidly — same day, not at your next scheduled appointment.

Did you know?

When cetuximab was first used widely, it was given to some patients whose tumours carried RAS mutations — where it cannot help.

ESMO and ASCO analysis later showed that identifying those patients through RAS testing and excluding them from treatment was itself a medical advance — one of the first large-scale demonstrations of biomarker-driven prescribing in oncology.

Source: ESMO Guidelines for Metastatic Colorectal Cancer; ASCO Clinical Practice Guidelines

Explore 100 more Gastrointestinal & Liver Targeted Medicines topics

All Gastrointestinal & Liver Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Will I definitely get a rash on cetuximab?

Most people who take cetuximab develop some degree of skin reaction, ranging from mild dryness to a more noticeable acneiform rash on the face, chest and back. Severity varies considerably from person to person. The fact that it is likely is not a reason to delay treatment — it is expected and manageable. Your team will advise on a skincare routine before your first infusion rather than waiting for symptoms to appear.

If the rash settles down during treatment, does that mean cetuximab has stopped working?

Not necessarily. The rash can improve or fluctuate for reasons unrelated to whether the drug is working — some people's skin adapts over the course of treatment. Whether cetuximab is working is assessed through scans and tumour markers at intervals your oncologist will explain to you. A change in your skin is not reliable information about your treatment response, and your oncologist will tell you what to watch for.

Can I use my normal face wash and skincare products?

Check with your team before continuing any product that contains alcohol, salicylic acid, benzoyl peroxide or retinoids, as these can irritate skin already affected by EGFR inhibition. Fragrance-free moisturisers and gentle cleansers are generally what teams recommend. If you are applying any traditional or herbal product to your skin, mention it — your team can only advise on what they know about.

How will my oncologist know if cetuximab is actually working?

Response is assessed through CT or PET-CT scans done at intervals during treatment, alongside blood tests and clinical review. Your oncologist will tell you when your first assessment scan is scheduled and what they are looking for. The rash is not part of that assessment. If you are unsure when your response will be evaluated, that is a straightforward question to ask at your next visit.

What is the difference between cetuximab and immunotherapy?

Cetuximab is a monoclonal antibody that targets EGFR, a receptor on cancer cell surfaces that drives their growth. Checkpoint inhibitors — what most people mean by immunotherapy — work differently: they remove signals that prevent your immune system from attacking cancer cells. The two approaches are distinct in how they work, their side-effect profiles, and which cancers they are used for. Cetuximab does not activate the immune system in the way checkpoint inhibitors do.

Call now Book free consultation